Literature DB >> 31841943

Oral trehalose maybe helpful for patients with spinocerebellar ataxia 3 and should be better evaluated.

M A Noorasyikin1, E A Azizan2, P C Teh3, T Farah Waheeda4, M D Siti Hajar5, K C Long6, M I Norlinah7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31841943     DOI： 10.1016/j.parkreldis.2019.12.007

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN： 1353-8020            Impact factor:   4.891


× No keyword cloud information.
  4 in total

Review 1.  Current and emerging treatment modalities for spinocerebellar ataxias.

Authors:  Shaila D Ghanekar; Sheng-Han Kuo; Joseph S Staffetti; Theresa A Zesiewicz
Journal:  Expert Rev Neurother       Date:  2022-02-10       Impact factor: 4.287

Review 2.  Mutant Ataxin-3-Containing Aggregates (MATAGGs) in Spinocerebellar Ataxia Type 3: Dynamics of the Disorder.

Authors:  Kritika Raj; Ravi Shankar Akundi
Journal:  Mol Neurobiol       Date:  2021-02-24       Impact factor: 5.590

3.  n-Butylidenephthalide Modulates Autophagy to Ameliorate Neuropathological Progress of Spinocerebellar Ataxia Type 3 through mTOR Pathway.

Authors:  Jui-Hao Lee; Si-Yin Lin; Jen-Wei Liu; Shinn-Zong Lin; Horng-Jyh Harn; Tzyy-Wen Chiou
Journal:  Int J Mol Sci       Date:  2021-06-13       Impact factor: 5.923

4.  Autophagy Upregulation by the TFEB Inducer Trehalose Protects against Oxidative Damage and Cell Death Associated with NRF2 Inhibition in Human RPE Cells.

Authors:  Samuel Abokyi; Sze Wan Shan; Chi-Ho To; Henry Ho-Lung Chan; Dennis Yan-Yin Tse
Journal:  Oxid Med Cell Longev       Date:  2020-07-21       Impact factor: 6.543
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.